论文部分内容阅读
临床病理研究的发展,对肺癌外科治疗原则的概念,产生新的影响。最大限度切除肺癌现在不只是切除肺内癌灶,而且包括纵隔淋巴结的清除。肺癌组织类型较复杂、生物学行为各导,其发展、预后及治疗各具特征。非小细胞肺癌对化疗放疗敏感性较差,其首选治疗方法是外科治疗。而小细胞肺癌发展快、转移早、复发多,预后劣。但对化疗较敏感。因此对这种具有较强的全身性疾病首选化疗。在选择手术适应症时对①肺癌组织类型②病期分级③肺
The development of clinical pathology studies has had a new impact on the concept of surgical treatment of lung cancer. Maximal resection of lung cancer is now not only the removal of intrapulmonary foci, but also the removal of mediastinal lymph nodes. Lung cancer has more complex tissue types and biological behaviors. Its development, prognosis and treatment have their own characteristics. Non-small cell lung cancer is less sensitive to chemoradiation, and its preferred treatment is surgical treatment. However, small cell lung cancer develops rapidly, metastasizes early, and relapses frequently, with a poor prognosis. However, it is more sensitive to chemotherapy. Therefore, chemotherapy is preferred for this type of systemic disease. In the choice of surgical indications for lung cancer tissue type 2 stage 3 lung